RecruitingNCT06887816

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections

Clinical Investigation of the Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections

Sponsor

Istituto Ortopedico Rizzoli

Enrollment

70 participants

Start Date

Mar 12, 2025

Study Type

OBSERVATIONAL

Conditions

Hip Infection

Summary

The aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indeed able to reduce the number of peri-operative and post-operative infections, both early and late.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Patients aged ≥ 18 years;
Immunocompromised patients and/or diabetic patients.
Patients who have given consent

Exclusion Criteria2

Patients aged < 18 years;
Pregnant women;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEsilver coated device

Patients who will be implanted with prosthesis with a silver coating to counteract infection relapse

DEVICEnot silver coated device

Patients who will be implanted with prosthesis without silver coating

Locations(2)

Istituto Ortopedico Rizzoli

Bologna, BO, Italy

Ospedale Mazzolani Vandini

Argenta, Italia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06887816